Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Rating Lowered by Sanford C. Bernstein

Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from a strong-buy rating to a hold rating in a report issued on Monday morning, Zacks.com reports.

Several other analysts have also recently commented on the company. JPMorgan Chase & Co. cut Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

View Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Up 0.7 %

OTCMKTS RBGLY opened at $12.89 on Monday. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $15.03. The company’s 50-day simple moving average is $12.22 and its 200 day simple moving average is $11.56. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.